BioAge Labs, Inc. - Common Stock, par value $0.00001 per share (BIOA)

CUSIP: 09077V100

Q2 2025 13F Holders as of 30 Jun 2025

Type / Class
Equity / Common Stock, par value $0.00001 per share
Shares outstanding
35,863,005
Total 13F shares
20,716,453
Share change
+490,109
Total reported value
$85,559,282
Price per share
$4.13
Number of holders
81
Value change
+$3,327,577
Number of buys
55
Number of sells
17

Quarterly Holders Quick Answers

What is CUSIP 09077V100?
CUSIP 09077V100 identifies BIOA - BioAge Labs, Inc. - Common Stock, par value $0.00001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of BioAge Labs, Inc. - Common Stock, par value $0.00001 per share (BIOA) as of Q2 2025

As of 30 Jun 2025, BioAge Labs, Inc. - Common Stock, par value $0.00001 per share (BIOA) was held by 81 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 20,716,453 shares. The largest 10 holders included AH CAPITAL MANAGEMENT, L.L.C., Sofinnova Investments, Inc., Cormorant Asset Management, LP, ADAR1 Capital Management, LLC, TANG CAPITAL MANAGEMENT LLC, VANGUARD GROUP INC, BlackRock, Inc., ORBIMED ADVISORS LLC, Sands Capital Alternatives, LLC, and Pivotal bioVenture Partners Investment Advisor LLC. This page lists 81 institutional shareholders reporting positions in this security for the Q2 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.